What is Syndax Pharmaceuticals, Inc.'s Market Cap?

Syndax Pharmaceuticals, Inc.'s Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s Enterprise Value?

Syndax Pharmaceuticals, Inc.'s Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s Price / Sales?

Syndax Pharmaceuticals, Inc.'s Price / Sales is 7.1×, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s EV / Revenue?

Syndax Pharmaceuticals, Inc.'s EV / Revenue is 6.3×, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s EV / EBITDA?

Syndax Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s Revenue (TTM)?

Syndax Pharmaceuticals, Inc.'s Revenue (TTM) is $252.3M, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s Net Income (TTM)?

Syndax Pharmaceuticals, Inc.'s Net Income (TTM) is -$220.8M, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s EBITDA?

Syndax Pharmaceuticals, Inc.'s EBITDA is -$179.2M, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Syndax Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -2.47, based on as-reported figures from SEC (XBRL) filings.

What is Syndax Pharmaceuticals, Inc.'s EBITDA Margin?

Syndax Pharmaceuticals, Inc.'s EBITDA Margin is -71.0%, based on as-reported figures from SEC (XBRL) filings.

Syndax Pharmaceuticals, Inc. (SNDX) Financial Statements

Syndax Pharmaceuticals, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001T92272

XNAS · usd

19.94▼ 0.62 (-3.02%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close20.56

Day's Range19.90 – 20.48

52-Week Range12.99 – 25.59

Volume1.2M

Avg Volume1.3M

Share Statistics

Shares Outstanding

Employees298

ExchangeXNAS

Listed2016-03-03

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Syndax Pharmaceuticals, Inc. (SNDX)

What is Syndax Pharmaceuticals, Inc.'s Market Cap?: Syndax Pharmaceuticals, Inc.'s Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s Enterprise Value?: Syndax Pharmaceuticals, Inc.'s Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s Price / Sales?: Syndax Pharmaceuticals, Inc.'s Price / Sales is 7.1×, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s EV / Revenue?: Syndax Pharmaceuticals, Inc.'s EV / Revenue is 6.3×, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s EV / EBITDA?: Syndax Pharmaceuticals, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s Revenue (TTM)?: Syndax Pharmaceuticals, Inc.'s Revenue (TTM) is $252.3M, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s Net Income (TTM)?: Syndax Pharmaceuticals, Inc.'s Net Income (TTM) is -$220.8M, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s EBITDA?: Syndax Pharmaceuticals, Inc.'s EBITDA is -$179.2M, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Syndax Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -2.47, based on as-reported figures from SEC (XBRL) filings.
What is Syndax Pharmaceuticals, Inc.'s EBITDA Margin?: Syndax Pharmaceuticals, Inc.'s EBITDA Margin is -71.0%, based on as-reported figures from SEC (XBRL) filings.